Metabolism and Cardiovascular Disease (CVD) are intricately linked, with metabolic dysregulation playing a pivotal role in the pathogenesis of cardiovascular conditions. Metabolic disorders such as diabetes, dyslipidaemia, and obesity contribute significantly to the global burden of CVD, amplifying risks through mechanisms like chronic inflammation, oxidative stress, and endothelial dysfunction. This article explores the molecular and clinical intersections between metabolism and cardiovascular health. It highlights advances in understanding metabolic pathways, their role in cardiovascular pathology, and emerging therapeutic strategies. By elucidating these connections, the article aims to guide future research and clinical interventions to mitigate the dual burden of metabolic and cardiovascular diseases.
